Skip to main content
. 2016 Jul 8;95(27):e3845. doi: 10.1097/MD.0000000000003845

Figure 6.

Figure 6

Meta-analysis of adverse event flushing comparing degarelix versus GnRH agonist therapy groups.

HHS Vulnerability Disclosure